Live Well with Michelle

Money and Me: The Great Singapore Investing Debate - Singtel, DBS, REITs or the STI?

28 min · 15. juni 2026
episode Money and Me: The Great Singapore Investing Debate - Singtel, DBS, REITs or the STI? cover

Description

Hosted by Michelle Martin, this episode brings together Willie Keng of Dividend Titan (https://www.dividendtitan.com) and Paul Chew of Phillip Securities for a high-stakes debate on some of the market's biggest investment questions. Has Singtel transformed itself from a steady telco into a compelling AI and digital infrastructure play, or has the market already priced in the good news? Is DBS still Singapore's crown jewel, or are investors paying too much for quality after a decade of stellar returns? The bulls and bears clash over whether Singapore REITs are finally back, whether the STI's best years still lie ahead, and whether investors should stick with the Magnificent Seven or start looking elsewhere. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Comments

0

Be the first to comment

Sign up now and become a member of the Live Well with Michelle community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

300 episodes

episode LIVE WELL WITH MICHELLE: Beyond Willpower, The New Science of Weight Loss artwork

LIVE WELL WITH MICHELLE: Beyond Willpower, The New Science of Weight Loss

Michelle speaks with the first Gastroenterologist in Singapore to be recognised as a National Fellow by World Obesity Federation, to find out about advances in weight control. As science transforms our understanding of obesity, experts now recognise it as a chronic disease shaped by biology, hormones and the brain - not just lifestyle choices. Hosted by Michelle Martin in conversation with Dr Ravishankar Asok-kumar, Senior Consultant, Gastroenterologist and Advanced Therapeutic Endoscopist at Singapore General Hospital, this episode explores why weight regain is so common, where GLP-1 medications and new minimally invasive treatments fit, and why personalised obesity care could change not just our weight, but our long-term health, confidence and quality of life.  See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

13. juli 202624 min